A 28-year-old woman from Mumbai with a history of systemic lupus erythematosus (SLE) on hydroxychloroquine presents with acute onset of left ankle pain, swelling, and warmth for 3 days. She denies trauma. Temperature is 38.8°C, and the ankle is visibly swollen with restricted dorsiflexion. Ankle aspiration yields cloudy fluid: WBC 45,000/μL (88% neutrophils), glucose 22 mg/dL (serum 110 mg/dL), protein 4.8 g/dL. Gram stain is negative. Blood cultures are sent. What is the most likely causative organism, and what is the recommended empiric antibiotic regimen?

Explanation

## Clinical Analysis and Organism Identification ### Synovial Fluid Findings | Finding | Value | Significance | |---------|-------|---------------| | WBC | 45,000/μL | Bacterial range (>50,000 is classic, but 30,000–50,000 is common) | | PMN % | 88% | Bacterial infection (>80% PMN) | | Glucose ratio | 22/110 = 0.2 | <0.5 = bacterial (not viral or inflammatory) | | Gram stain | Negative | Does NOT exclude bacterial infection; 30–50% of gonococcal and some S. aureus cases are Gram-stain negative | | Appearance | Cloudy | Consistent with bacterial infection | **Key Point:** A negative Gram stain does NOT rule out bacterial septic arthritis. Culture is the gold standard. ### Organism Likelihood in This Patient **High-Yield:** The most common cause of acute bacterial septic arthritis in adults is **Staphylococcus aureus** (~50–70% of cases), regardless of underlying comorbidity. ```mermaid flowchart TD A[Acute monoarthritis + fever + synovial WBC 45k]:::outcome --> B{Risk factors?}:::decision B -->|IVDU, prosthesis| C[S. aureus + Gram-negative]:::outcome B -->|Young, sexually active| D[N. gonorrhoeae]:::outcome B -->|TB exposure, immunocompromised| E[M. tuberculosis]:::outcome B -->|No specific risk| F[S. aureus most likely]:::outcome C --> G[Vancomycin + ceftriaxone]:::action D --> H[Ceftriaxone + azithromycin]:::action E --> I[TB drugs after culture]:::action F --> G ``` ### Why S. aureus in This Patient? 1. **Epidemiology:** S. aureus causes ~60% of non-gonococcal acute septic arthritis in adults 2. **SLE is NOT a risk factor for gonococcal arthritis** — gonococcal arthritis occurs in young, sexually active individuals with disseminated gonococcal infection (DGI), often with pustular rash 3. **No sexual history or DGI stigmata mentioned** — reduces likelihood of N. gonorrhoeae 4. **TB arthritis is subacute/chronic** — typically insidious onset over weeks to months, not acute 3-day presentation 5. **Gram-negative organisms** (E. coli, Klebsiella) are less common in community-acquired monoarthritis without IVDU or prosthesis **Clinical Pearl:** SLE patients have increased infection risk due to immunosuppression (hydroxychloroquine + possible corticosteroids), but S. aureus remains the most likely organism in acute septic arthritis. ### Empiric Antibiotic Regimen **Key Point:** Empiric therapy must cover both methicillin-sensitive and methicillin-resistant S. aureus (MSSA and MRSA). #### Recommended: Vancomycin + Ceftriaxone | Drug | Dose | Rationale | |------|------|----------| | **Vancomycin** | 15–20 mg/kg IV 8-hourly | Covers MRSA; excellent synovial penetration | | **Ceftriaxone** | 2 g IV 12-hourly | Covers MSSA, streptococci, Gram-negative bacilli; synergistic with vancomycin | **High-Yield:** This combination provides: - Broad empiric coverage pending culture - Synergistic bactericidal activity - Excellent bone and synovial fluid penetration - Standard of care in acute septic arthritis #### Culture-Directed Therapy (After 48–72 hours) Once organism is identified: - **S. aureus (MSSA):** Switch to oxacillin or nafcillin 2 g IV 4-hourly - **S. aureus (MRSA):** Continue vancomycin - **Streptococcus spp.:** Penicillin G or ceftriaxone - **Gram-negative bacilli:** Ceftriaxone or fluoroquinolone ### Why Other Options Are Incorrect **Warning:** Do NOT narrow empirically to monotherapy or organism-specific drugs without culture confirmation. **Mnemonic:** **GRAM** approach to empiric coverage: - **G**ram-positive (S. aureus, streptococci) → vancomycin - **R**esistance (MRSA) → vancomycin - **A**erobic Gram-negative → cephalosporin - **M**ultiple organisms → combination therapy ### Surgical Management **Key Point:** Urgent arthroscopic washout is mandatory alongside antibiotics. Do NOT delay surgery waiting for culture results.